COMPANY INTELLIGENCE PROFILE

Comship Medix And Infra Private Limited

Trades under the brand "BlueMedix" (BlueMedix – Retail Chain Pharmacy, originally an online pharmacy launched 2015).

Active (Private Limited, non-govt company limited by shares); Active Compliant; DPIIT-recognised Startup [TheCompanyCheck]Unlisted [TheCompanyCheck]RoC Patna, Registration No. 034928; Regional Directorate: RD Kolkata (Eastern Region) [QorpIQ, TheCompanyCheck]
AI Overview Generating…

Founded on 22 June 2017, BlueMedix operates as a private limited company in the pharmaceutical sector, focusing on franchise-model pharmacy retail. It runs approximately 130 stores in Bihar, Jharkhand, Uttar Pradesh, and Madhya Pradesh, offering affordable medications and health products. Its FY2022 revenue reached ₹25.05 Cr, and it secured US$5 million funding in 2025 for expansion. The company aims to reach 5,000 outlets and an IPO within five years.

AI-generated, may contain errors.

Business Overview

  • Trades under the brand "BlueMedix", BlueMedix – Retail Chain Pharmacy, originally an online pharmacy launched 2015.
  • Runs a franchise-model multi-brand pharmacy retail chain selling genuine, affordable generic medicines, OTC products and general health/FMCG items, protein powder, baby diapers, antiseptics, etc. per IndiaMART listing.
  • As of the funding announcement (Jan 2025) operated ~130 stores across Bihar, Jharkhand, Uttar Pradesh and Madhya Pradesh, an earlier 2024 source cited 100+ stores across Bihar/Jharkhand serving ~25,000 customers/day
  • Corporate office subsequently relocated to Delhi NCR.
  • Vision: "Affordable Healthcare for all," targeting 5,000 outlets and 50 million annual customers within 5 years, IPO planned in 2-3 years.
  • Sources: Tata nexarc, BusinessOutreach.in, StartupChronicle.in, TheCompanyCheck.

Sector & Classification

NIC 511/51100 — Wholesale trade on a fee/commission basis; commercial classification shown as "Pharma – Pharmaceutical Retailers & Distributors" [TheCompanyCheck, QorpIQ, Falconebiz]. Note: CIN's activity-code digits changed from 45500 (former name/classification) to 51100 (current) — see note below.

Directors & Key Management

Directors — source notes

Current directors per TheCompanyCheck (3): Mohammad Rais Azam — Founder, Managing Director/CEO, appointed 22 Jun 2017, DIN 07673310; Mohammad Faiyaz Alam — Co-Founder Director/Chief Procurement Officer, appointed 22 Jun 2017, DIN 07673303; Gaurav Prakash — Director/Chief Marketing Officer, appointed 16 Apr 2022, DIN 09573377. Additional KMPs/associated persons listed by QorpIQ (6 DINs total, active status; roles per Tata nexarc bios — not all necessarily current board directors, flagged as partial): Sanjay Choudhary — Co-Founder, Chief Administrative Officer, DIN 08915473; Brajesh Kumar Pandey (listed as "Avijit Bimal Choudhary" ordering aside) — Chairman/Director for Training & Compliance, ex-Indian Army Medical Services, DIN 09072586; Avijit Bimal Choudhary — DIN 03609814 (role not identified in business bios; oldest DIN, likely an early/exited director — confirm before publishing). Source conflict: QorpIQ's 6-name KMP list vs TheCompanyCheck's 3 current directors — likely reflects past+present KMPs; DINs are corroborated across QorpIQ only (single source for DIN numbers), so treat DINs as partial confidence.

GST Registrations

Primary/home-state GSTIN: 10AAHCC0658E1Z8 (Bihar), registered 24 Jul 2017, Principal place of business = registered office (Shashi Complex, Patna) [gst.iadv.io]. Second registration: 20AAHCC0658E1Z7 (Jharkhand), registered 07 Jul 2022, status CANCELLED effective 01 Jun 2024, address A-K Residency, Bariatu, Ranchi [gst.iadv.io, KnowYourGST, MastersIndia]. PAN (derived from GSTIN structure): AAHCC0658E. Total confirmed registrations: 2 (1 active in Bihar, 1 cancelled in Jharkhand). Possible additional registrations in UP/MP (per 2025 store-expansion reporting) not confirmed — "not obtained."

Financials

AI Overview Generating…

Comship Medix And Infra Private Limited reported a revenue of ₹25.05 Cr for FY2022, marking a 1092% YoY increase. The company has open borrowings of ₹4.25 Cr. Employee count grew by 107% YoY to 203 as of April 2024.

AI-generated, may contain errors.

  • Standalone, FY2022, i.e., FY ending 31 Mar 2022, per Tofler-style FY labeling as shown on TheCompanyCheck: Revenue ₹25.05 Cr, reported as +1092% YoY. EBITDA and Net Profit: locked/paywalled — not obtained. Balance sheet date on file: 31 Mar 2023
  • Last AGM 30 Sep 2023
  • Auditor Vikash Gupta & Co. (FY2022).
  • Open charges/borrowings: ₹4.25 Cr total — Canara Bank ₹3.00 Cr, charge created 30 Mar 2022, + others ₹1.25 Cr, charge created 04 Dec 2023, [TheCompanyCheck, QorpIQ].
  • No FY2023/FY2024 audited figures found publicly.
  • EPFO-registered employee count 203 (as of Apr 2024), +107% YoY growth — proxy for headcount, not a financial figure per se.

Funding History

  • Pre-Series A / Seed round: US$5 million, announced 20 Jan 2025, led by an undisclosed Dubai-based family fund, investor name not disclosed in any source.
  • Valuation not disclosed.
  • Stated use of funds: geographic expansion into South/West/Central India, a central warehouse in Delhi NCR, recruitment and marketing. [StartupChronicle.in, BusinessOutreach.in, Tracxn, round type/date corroboration only, per task's Tracxn-restricted-use rule, TheCompanyCheck]

Loans & Charges

  • Open charges totaling ₹4.25 Cr: Canara Bank ₹3.00 Cr, created 30 Mar 2022
  • Other lender (s) ₹1.25 Cr, created 04 Dec 2023, — lender name for the second charge not disclosed. [TheCompanyCheck, QorpIQ]

Competitive Landscape

  • Tata 1mg, large, PharmEasy/Reliance-backed, pan-India online+offline, PharmEasy, large, pan-India e-pharmacy, Netmeds, large, Reliance-owned e-pharmacy, MedPlus, large, listed pan-India pharmacy retail chain, SastaSundar, mid, eastern-India-focused online pharmacy — closest regional peer, Truemeds, mid, generics-focused e-pharmacy, Medlife, mid, e-pharmacy, merged into PharmEasy, Healthskool Pharmacy and Tablt, small/regional peers, [TheCompanyCheck competitor list].

Frequently Asked Questions

What does the company do?

The company trades under the brand 'BlueMedix', operating a franchise-model multi-brand pharmacy retail chain selling genuine, affordable generic medicines, OTC products, and general health/FMCG items. It aims for affordable healthcare, targeting 5,000 outlets and 50 million annual customers within 5 years, with an IPO planned in 2-3 years.

What is the company's CIN?

The company's CIN is U51100BR2017PTC034928.

What is the company's GSTIN?

The primary/home-state GSTIN for the company is 10AAHCC0658E1Z8 registered in Bihar. There was a second registration, 20AAHCC0658E1Z7 in Jharkhand, which was cancelled effective 01 June 2024.

When was the company incorporated?

The company was incorporated on 22 June 2017.

What is the company's registered office address?

The registered office is located at Flat No. 302, 3rd Floor, Shashi Palace/Shashi Complex, Near Kulhariya Complex, Bankipur, Ashok Raj Path, Patna, Bihar 800004, India.

Sources

TheCompanyCheck (thecompanycheck.com) — primary registry-style source, identity/financials/directors/competitors; QorpIQ (qorpiq.com) — capital structure, DINs, NIC code; Falconebiz (falconebiz.com, via DDG snippet) — CIN/registration-number corroboration; Tata nexarc (tatanexarc.com) — detailed business overview, leadership bios; gst.iadv.io — primary Bihar GSTIN full record; KnowYourGST (knowyourgst.com) and MastersIndia (mastersindia.co) — Jharkhand GSTIN corroboration; StartupChronicle.in and BusinessOutreach.in — funding round detail; Tofler (tofler.in) — old-CIN record (used only for the CIN-history note, flagged as conflicting); Indian Kanoon (indiankanoon.org) — legal-case check (none found).

Information compiled from public registry and secondary sources. It may be incomplete or dated; verify independently before relying on it.